2012
DOI: 10.1007/s00125-012-2565-6
|View full text |Cite
|
Sign up to set email alerts
|

Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment

Abstract: Aims/hypothesis The aim of this study was to analyse whether the increased mortality rates observed in insulintreated patients with type 2 diabetes and coronary artery disease are explained by comorbidities and complications. Methods A retrospective analysis of data from two Swedish registries of type 2 diabetic patients (n012,515) undergoing coronary angiography between the years 2001 and 2009 was conducted. The association between glucose-lowering treatment and long-term mortality was studied after extensive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 28 publications
0
18
0
Order By: Relevance
“…Population-based studies in patients with T2D reported recently from Canada, the U.K., and Sweden have shown, after correction for multiple factors, increased risk of mortality in patients with T2D treated with insulin (6163). A follow-up analysis of DIGAMI 2, using the total cohort as an epidemiological database, also showed that insulin therapy from the time of hospital discharge was associated with a significant increased risk of the composite of death, reinfarction, or stroke (HR 1.78 [95% CI 1.14–2.40]) (57).…”
Section: T2d Clinical Studies and The Concept Of Insulin-induced Metamentioning
confidence: 99%
“…Population-based studies in patients with T2D reported recently from Canada, the U.K., and Sweden have shown, after correction for multiple factors, increased risk of mortality in patients with T2D treated with insulin (6163). A follow-up analysis of DIGAMI 2, using the total cohort as an epidemiological database, also showed that insulin therapy from the time of hospital discharge was associated with a significant increased risk of the composite of death, reinfarction, or stroke (HR 1.78 [95% CI 1.14–2.40]) (57).…”
Section: T2d Clinical Studies and The Concept Of Insulin-induced Metamentioning
confidence: 99%
“…In a recent report on patients with type 2 diabetes mellitus undergoing coronary angiography, where such variables were adjusted for, the increased mortality risk related to insulin treatment was reduced but was still apparent. 26 So, it was not possible to rule out whether insulin per se affects the event rate or whether the use of insulin therapy is a risk variable confounded by indication. On the contrary, data from the recent Outcome Reduction With Initial Glargine Intervention (ORIGIN) study 27 contradict this former possibility, showing a neutral effect of insulin on cardiovascular outcome compared with standard glucose care in individuals at high cardiovascular risk and previously insulin naïve patients.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…One large clinical trial found that treatment with insulin in patients with myocardial infarction was associated with an enhanced risk of recurrent nonfatal myocardial infarction or stroke, while treatment with metformin was more beneficial [5]. Another study found that insulin treatment with or without oral glucose-lowering therapy was associated with higher long-term mortality in patients with DM undergoing coronary angiography [6].…”
Section: Introductionmentioning
confidence: 97%